CINECA IRIS Institutional Research Information System

VIGATO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 389
EU - Europa 323
AS - Asia 148
SA - Sud America 5
AF - Africa 4
OC - Oceania 2
Totale 871
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 384
IT - Italia 202
SG - Singapore 82
IE - Irlanda 48
CN - Cina 25
GB - Regno Unito 20
IN - India 16
HK - Hong Kong 11
SE - Svezia 11
DE - Germania 8
PT - Portogallo 8
FR - Francia 5
CZ - Repubblica Ceca 4
JP - Giappone 4
NG - Nigeria 4
CA - Canada 3
ES - Italia 3
HU - Ungheria 3
UA - Ucraina 3
AU - Australia 2
BR - Brasile 2
CL - Cile 2
FI - Finlandia 2
IR - Iran 2
KR - Corea 2
MX - Messico 2
NL - Olanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
BO - Bolivia 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
LV - Lettonia 1
PK - Pakistan 1
TH - Thailandia 1
Totale 871
Salva come PNG Salva come JPEG
Città #
Los Angeles 98
Singapore 67
Turin 67
Dublin 48
Santa Clara 33
Chandler 32
Rome 26
Milan 25
Columbus 18
Nyköping 11
Ashburn 10
Lisbon 8
Lucknow 8
Bradford 6
Leeds 6
Rivoli 6
Washington 5
Abuja 4
Bad Rappenau 4
Luni 4
Medford 4
Naples 4
Princeton 4
Alessandria 3
Barcelona 3
Boardman 3
Budapest 3
Florence 3
Garbagnate Milanese 3
Bari 2
Birmingham 2
Bratislava 2
Brooklyn 2
Buffalo 2
Chicago 2
Cincinnati 2
Cinisello Balsamo 2
Fort Worth 2
Gunzenhausen 2
Hradec Králové 2
Jacksonville 2
João Pessoa 2
Lake Dallas 2
Lappeenranta 2
Manchester 2
Modena 2
Montreal 2
New Hope 2
Nice 2
Olomouc 2
Osaka 2
Paddington 2
Parma 2
Scarborough 2
Talca 2
Vercelli 2
Wanchai 2
West Jordan 2
Alghero 1
Amsterdam 1
Bangkok 1
Barletta 1
Basingstoke 1
Beijing 1
Bengaluru 1
Berlin 1
Besançon 1
Bologna 1
Borgone Susa 1
Boston 1
Caltagirone 1
Canberra 1
Candiac 1
Central 1
Cheonan 1
College Station 1
Franois 1
Gainesville 1
Gangdong-gu 1
Genzano di Roma 1
Grinzane Cavour 1
Guadalajara 1
Guangzhou 1
Islamabad 1
Jakarta 1
Jerusalem 1
Kanazawa 1
London 1
Mumbai 1
New York 1
Nishiōizumi 1
Noicattaro 1
Palermo 1
Polignano a Mare 1
Pune 1
Reston 1
Saluzzo 1
San Luis Potosí City 1
Santa Cruz 1
Seattle 1
Totale 616
Salva come PNG Salva come JPEG
Nome #
New inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) based on benzoisoxazole scaffold and their potential application in cancer 120
Design of new human Dihydroorotate Dehydrogenase inhibitors: amide bioisosterism in MEDS433 optimization 95
New Hydroxybenzoazole Inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3): Disclosure of SAR Investigation to Target Prostate Cancer 92
Improvement of metabolic weakness of new human Dihydroorotate Dehydrogenase inhibitors based on 2-hydroxypyrazolo[1,5-a]pyridine scaffold 52
Targeting myeloid leukemias using human Dihydroorotate Dehydrogenase inhibitors based on 2-hydroxypyrazolo[1,5-a]pyridine scaffold: overcoming of metabolic issues 45
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 41
Targeting Acute Myelogenous Leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2-hydroxypyrazolo[1,5-a]pyridine scaffold: from academy to clinic 39
Targeting Myeloid Leukemias Using human Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: Overcoming of Metabolic Issues 36
Important steps into drug development of MEDS433, a potent human dihydroorotate dehydrogenase inhibitor based on the 2-hydroxypyrazolo[1,5-a]pyridine scaffold 36
HYDROXYLATED HETEROCYCLES AS BIOISOSTERES OF THE CARBOXYLIC FUNCTION: DESIGN OF NEW AKR1C3 INHIBITORS ACTIVE IN PROSTATE CANCER 34
Targeting Acute Myelogenous Leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2- hydroxypyrazolo[1,5-a]pyridine scaffold: from academy to clinic 34
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 31
Important Steps into Drug Development of MEDS433, a Potent Human Dihydroorotate Dehydrogenase Inhibitor based on the 2-hydroxypyrazolo[1,5-a] Pyridine Scaffold 30
Phenothiazines as anti-cancer agents: SAR overview and synthetic strategies 29
A new generation of AKR1C3 inhibitors on the horizon: the 3- hydroxybenzazole approach to target prostate cancer 28
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer 27
Enhancement of the metabolic stability in 2-hydroxypyrazolo[1,5-a]pyridine scaffold-based inhibitors of human dihydroorotate dehydrogenase (hDHODH) 26
Improvement of Metabolic Weakness of New Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold to Target Myeloid Leukemias 25
Overcoming of metabolic issues in 2-hydroxypyrazolo[1,5-a]pyridine scaffold-based inhibitors of human dihydroorotate dehydrogenase: the story of MEDS700 21
AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications 20
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies 18
Improvement of Metabolic Weakness of New Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold to Target Myeloid Leukemias 15
Optimization of MEDS433 synthesis: scale-up for preclinical evaluation studies 13
The (bio)chemical beaUty: La bellezza del faRmaCo attraverso la ReAltà Virtuale (URCA!) 5
Totale 912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.920
article - articoli 0
book - libri 0
conference - conferenze 4.333
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.253
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 0 0 0 0 0 0 0 0 10 21 13
2022/2023252 22 18 12 9 10 86 29 13 16 4 15 18
2023/2024345 30 25 14 14 12 26 133 13 4 22 23 29
2024/2025271 31 41 61 55 83 0 0 0 0 0 0 0
Totale 912